Brucella Broth Preservation for Helicobacter Pylori Resistance Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting antibiotic-resistant Helicobacter pylori genotypes, such as culture-based antimicrobial susceptibility testing and molecular testing, are time-consuming and inefficient, leading to low eradication rates of Helicobacter pylori infections.
Innovation Solution
A method for preserving test samples using brucella broth, combined with primer sets targeting 23S rRNA and gyrA genes for PCR-based detection, and a reagent kit for accurately identifying antibiotic-resistant genotypes, followed by tailored treatment regimens.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If culture-based antimicrobial susceptibility testing is used to guide Helicobacter pylori eradication therapy, then treatment efficacy is improved, but testing time and operational complexity increase significantly
Solution Approach 1:
The patent replaces the traditional culture-based mechanical testing system with a molecular biology-based detection system. By using PCR amplification and hybridization probes to detect antibiotic resistance genes directly from clinical samples, the method eliminates the need for time-consuming bacterial culture while maintaining accurate resistance detection, thereby resolving the contradiction between treatment efficacy and testing time
Solution Approach 2:
The patent creates molecular copies (DNA amplification) of the antibiotic resistance genetic markers instead of relying on phenotypic expression through bacterial culture. This copying approach allows direct detection of resistance genes from clinical samples, significantly reducing testing time while preserving the reliability needed for guiding effective eradication therapy
2Productivity
If molecular testing for gene mutations is used to guide Helicobacter pylori treatment, then testing speed is improved, but eradication rate remains insufficient
Solution Approach 1:
The patent segments the detection process into multiple targeted components: detecting 23S rRNA mutations for clarithromycin resistance, gyrA mutations for levofloxacin resistance, and amoxicillin resistance genes. This segmented multi-gene detection approach maintains fast molecular testing speed while improving eradication rates by providing comprehensive resistance profiling to guide optimal antibiotic selection
Solution Approach 2:
The patent changes the detection parameters from single-gene or limited-gene testing to a comprehensive multi-parameter panel covering multiple antibiotic resistance mechanisms. By simultaneously detecting mutations in 23S rRNA, gyrA, and amoxicillin resistance genes, the method maintains molecular testing speed while significantly improving treatment reliability through more complete resistance characterization
3Ease of operation
If empirical therapy is used for Helicobacter pylori eradication, then treatment simplicity is improved, but eradication rate decreases due to antibiotic resistance
Solution Approach 1:
The patent performs preliminary molecular detection of antibiotic resistance genes before initiating eradication therapy. By pre-identifying which antibiotics the Helicobacter pylori strain is resistant to through rapid molecular testing, the system enables clinicians to select effective antibiotics in advance, maintaining treatment simplicity while overcoming the limitations of empirical therapy caused by antibiotic resistance
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Improves the efficiency and accuracy of detecting and treating antibiotic-resistant Helicobacter pylori, enhancing eradication rates beyond existing methods.
Implementation Method 1
preserving the test sample in a brucella broth
Implementation Method 2
performing a polymerase chain reaction on the test sample using the primer set of the reagent kit to obtain a product
Data Source
AI summary
The present disclosure provides methods for effectively preserving test samples utilized in detecting Helicobacter pylori. The present disclosure also provides methods for accurately detecting antibiotic-resistant genotypes of Helicobacter pylori, as well as methods for treating Helicobacter pylori infected-diseases. The disclosed methods effectively improve the efficiency and practicality of both detecting and treating antibiotic-resistant Helicobacter pylori.

